Elanco Animal Health and Bayer
C-4725 | Federal Trade Commission
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.In July 2020, the FTC required global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elanco’s proposed $7.6 billion acquisition of Bayer would likely be anticompetitive in those markets. On Sept. 11, 2020, the Commission announced the final consent agreement in this matter.
Filing Date | # | Docket Text |
---|